Physician profile
Ryan C Pollina
NPI 1255635405
$144,493.05
in general payments reported to CMS, 2019-2025
16 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2021: $10K · 2022: $34K · 2023: $35K · 2024: $19K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $59K · Travel and Lodging: $5,394 · Food and Beverage: $2,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $58,562.50 |
| Travel and Lodging | $5,393.54 |
| Food and Beverage | $2,892.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $73,863.51 | 2019-2022 | |
| Curonix LLC | $65,550.20 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertiflex, INC. | $1,825.31 | 2019 | |
| Nevro Corp. | $1,750.54 | 2019-2024 | Senza |
| Boston Scientific Corporation | $792.31 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Vertos Medical, INC. | $188.76 | 2023-2024 | Mild Device Kit |
| Nalu Medical, INC. | $158.65 | 2022-2023 | Nalu Neurostimulation System |
| Checkpoint Surgical, INC | $117.27 | 2024 | Checkpoint Stimulators |
| Averitas Pharma INC. | $59.42 | 2024-2025 | Qutenza |
| Relievant Medsystems, INC. | $53.18 | 2022 | |
| Stryker Corporation | $43.56 | 2025 | |
| Medtronic USA, INC. | $21.21 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $19.09 | 2024 | Dysport |
| Spinal Simplicity, LLC | $17.75 | 2025 | Ha Minuteman G3-R |
| Foundation Fusion Solutions, LLC | $17.67 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Pollina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.